Escitalopram for Severe Asthma and Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study

Psychosomatics

Volumn 53, Issue 1, 2012, Pages 75-80

  Brown, E Sherwood ^a   Howard, Christina ^a   Khan, David A ^b   Carmody, Thomas J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ESCITALOPRAM; ANTIDEPRESSANT AGENT; CITALOPRAM; PLACEBO;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; UNCONSCIOUSNESS; ADOLESCENT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PILOT STUDY; PSYCHOLOGICAL RATING SCALE; REGRESSION ANALYSIS; REMISSION; SELF REPORT; SPIROMETRY; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ASTHMA; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; REMISSION INDUCTION; SELF REPORT; SPIROMETRY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859538754     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2011.07.009     Document Type: Article

References (40)

1. Rhodes L.M.J., Redd S.C., Mannino D.M. Division of Environmental Hazards and Health Effects, National Center for Environmental Health, CDC. Self-reported asthma prevalence and control among adults-United States, 2001. MMWR Morb Mortal Wkly Rep 2003, 52:381-384.
2. Morgan M., Khan D.A. Asthma: epidemiology, burden, and quality of life. Adv Psychosom Med 2003, 24:1-15.
3. Weiss K.B., Sullivan S.D. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001, 107:3-8.
4. Weitzman M., Gortmaker S.L., Sobol A.M., et al. Recent trends in the prevalence and severity of childhood asthma. JAMA 1992, 268:2673-2677.
5. Evans R., Mullally D.I., Wilson R.W., et al. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965-1984. Chest 1987, 91(6 Suppl):65S-74S.
6. Weiss K.B., Wagener D.K. Changing patterns of asthma mortality. Identifying target populations at high risk. JAMA 1990, 264:1683-1687.
7. Crain E.F., Weiss K.B., Bijur P.E., et al. An estimate of the prevalence of asthma and wheezing among inner-city children. Pediatrics 1994, 94:356-362.
8. Evans R. Asthma among minority children. A growing problem. Chest 1992, 101(6 Suppl):368S-371S.
9. Ray N.F., Thamer M., Fadillioglu B., et al. Race, income, urbanicity, and asthma hospitalization in California: a small area analysis. Chest 1998, 113:1277-1284.
10. Patton L.M., Saggart B.S., Ahmed N.K., et al. Interleukin-1 β-induced neutrophil recruitment and acute lung injury in hamsters. Inflammation 1995, 19:23-29.
11. Nejtek V.A., Brown E.S., Khan D.A., et al. Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic. Ann Allergy Asthma Immunol 2001, 87:129-133.
12. Brown E.S., Khan D.A., Mahadi S. Psychiatric diagnoses in inner city outpatients with moderate to severe asthma. Int J Psychiatry Med 2000, 30:319-327.
13. Zielinski T.A., Brown E.S., Nejtek V.A., et al. Depression in Asthma: prevalence and clinical implications. Primary Care Companion J Clin Psychiatry 2000, 2:153-158.
14. Zielinski T.A., Brown E.S. Depression in patients with asthma. Adv Psychosom Med 2003, 24:42-50.
15. Brown E.S.K.D., Nejtek V.S., Thomas N.R., et al. Depressive symptoms and functioning in asthma patients. Primary Care Psychiatry 2000, 6:155-161.
16. Afari N., Schmaling K.B., Barnhart S., et al. Psychiatric comorbidity and functional status in adult patients with asthma. J Clin Psycho Med Settings 2001, 8:245-252.
17. Lavoie K.L., Bacon S.L., Barone S., et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?. Chest 2006, 130:1039-1047.
18. Mancuso C.A., Rincon M., McCulloch C.E., et al. Self-efficacy, depressive symptoms, and patients' expectations predict outcomes in asthma. Med Care 2001, 39:1326-1338.
19. Stein M.B., Cox B.J., Afifi T.O., et al. Does co-morbid depressive illness magnify the impact of chronic physical illness?. A population-based perspective. Psychol Med 2006, 36:587-596.
20. ten Brinke A., Ouwerkerk M.E., Zwinderman A.H., et al. Psychopathology in patients with severe asthma is associated with increased health care utilization. Am J Respir Crit Care Med 2001, 163:1093-1096.
21. Eisner M.D., Katz P.P., Lactao G., et al. Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 2005, 94:566-574.
22. Baiardini I., Braido F., Giardini A., et al. Adherence to treatment: assessment of an unmet need in asthma. J Investig Allergol Clin Immunol 2006, 16:218-223.
23. Bosley C.M., Fosbury J.A., Cochrane G.M. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995, 8:899-904.
24. Smith A., Krishnan J.A., Bilderback A., et al. Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest 2006, 130:1034-1038.
25. Miller B.D., Strunk R.C. Circumstances surrounding the deaths of children due to asthma. A case-control study. Am J Dis Child 1989, 143:1294-1299.
26. Mitchell I., Tough S.C., Semple L.K., et al. Near-fatal asthma: a population-based study of risk factors. Chest 2002, 121:1407-1413.
27. Heaney L.G., Conway E., Kelly C., et al. Prevalence of psychiatric morbidity in a difficult asthma population: relationship to asthma outcome. Respir Med 2005, 99:1152-1159.
28. Katon W.J., Richardson L., Russo J., et al. Quality of mental health care for youth with asthma and comorbid anxiety and depression. Med Care 2006, 44:1064-1072.
29. Brown E.S., Vigil L., Khan D.A., et al. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biol Psychiatry 2005, 58:865-870.
30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
31. First M.B., Spitzer R.L., Gibbon M., et al. Structured clinical interview for DSM-IV axis I disorders (SCID-I)-research version 2005, Biometrics Research, New York State Psychiatric Institute, New York, Revision 2005 Contract no.
32. Rush A.J., Gullion C.M., Basco M.R., et al. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med 1996, 26:477-486.
33. Rush A.J.C.T., Reimitz P.E. The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000, 9:45-59.
34. Trivedi M.H., Rush A.J., Ibrahim H.M., et al. The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004, 34:73-82.
35. Juniper E.F., O'Byrne P.M., Guyatt G.H., et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907.
36. Thase M.E., Fava M., Halbreich U., et al. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996, 53:777-784.
37. Kashner T.M., Carmody T.J., Suppes T., et al. Catching up on health outcomes: the Texas Medication Algorithm Project. Health Serv Res 2003, 38(1 Pt 1):311-331.
38. Wolfinger R., O'Connell M. Generalized linear models: a pseudo-likelihood approach. J Statist Comput Simul 1993, 48:233-243.
39. Feingold A. Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis. Psychol Methods 2009, 14:43-53.
40. Raudenbush S.W., Xiao-Feng L. Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychol Methods 2001, 6:387-401.